Close
  • Home

CAR-T Digest - August 2020

CAR-T Digest - August 2020

CAR-T Digest - August 2020

CAR-T Digest - August 2020

Funding

Clinical  ·  Weekly Digest 01 March to 07 March 2025
SOTIO unveils promising preclinical data on SOT109, a next-gen ADC targeting Cadherin-17 (CDH17) for colorectal cancer

Weekly Digest – March 2025 Weekly Digest – March 2025 03 March 2025: SOTIO unveils promising preclinical data on SOT109, a next-gen ADC targeting Cadherin-17 (CDH17) for colorectal cancer SOTIO Biotech presented the first preclinical data on SOT109, an antibody-drug […]

by Sandhya Ramalingam

Continue Reading
Clinical  ·  Weekly Digest 01 March to 07 March 2025
PinoBio announces results of dual-payload ADC platform research

Weekly Digest – March 2025 Weekly Digest – March 2025 07 Mar 2025: PinoBio announces results of dual-payload ADC platform research PinoBio presented research at World ADC London 2025, demonstrating the superior efficacy of its dual-payload ADC platform compared to […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly Digest 22 Feb to 28 Feb 2025
Pyxis Oncology granted FDA Fast Track Designation for PYX-201 monotherapy in patients with recurrent or metastatic head and neck cancer

Weekly Digest – February 2025 Weekly Digest – February 2025 26 Feb 2025: Pyxis Oncology granted FDA fast track designation for PYX-201 monotherapy in patients with recurrent or metastatic head and neck cancer The FDA has granted Fast Track Designation […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly Digest 22 Feb to 28 Feb 2025
Hansoh Pharma’s HS-20093 receives Breakthrough Therapy Designation from NMPA for Osteosarcoma

Weekly Digest – February 2025 Weekly Digest – February 2025 25 Feb 2025: Hansoh Pharma’s HS-20093 receives Breakthrough Therapy Designation from NMPA for Osteosarcoma Hansoh Pharma’s B7-H3-targeted ADC, HS-20093, has been granted Breakthrough Therapy Designated Drug status by China’s NMPA […]

by Sandhya Ramalingam

Continue Reading
Deals  ·  Weekly Digest 22 Feb to 28 Feb 2025
Akeso highlights collaboration between its partner Summit Therapeutics and Pfizer to explore Ivonescimab in combination with Pfizer’s ADCs

Weekly Digest – February 2025 Weekly Digest – February 2025 24 Feb 2025: Akeso highlights collaboration between its partner Summit Therapeutics and Pfizer to explore Ivonescimab in combination with Pfizer’s ADCs Akeso announced that its partner, Summit Therapeutics, has collaborated […]

by Sandhya Ramalingam

Continue Reading
Deals  ·  Weekly Digest 22 Feb to 28 Feb 2025
MEDSIR & Debiopharm announce the first patient dosed in the WIN-B trial exploring the combination of Debio 0123 & Gilead’s Trodelvy in advanced breast cancer

Weekly Digest – February 2025 Weekly Digest – February 2025 25 Feb 2025: MEDSIR & Debiopharm announce the first patient dosed in the WIN-B trial exploring the combination of Debio 0123 & Gilead’s Trodelvy in advanced breast cancer Debiopharm and […]

by Sandhya Ramalingam

Continue Reading
Clinical  ·  Weekly Digest 22 Feb to 28 Feb 2025
First patient dosed in a Phase 3 clinical study of anti-HER2 biparatopic ADC JSKN003 for the treatment of HER2-positive breast cancer

Weekly Digest – February 2025 Weekly Digest – February 2025 27 Feb 2025: First patient dosed in a Phase 3 clinical study of anti-HER2 biparatopic ADC JSKN003 for the treatment of HER2-positive breast cancer Alphamab Oncology and CSPC have initiated […]

by Sandhya Ramalingam

Continue Reading
Clinical  ·  Weekly Digest 22 Feb to 28 Feb 2025
OS Therapies forms subsidiary OS Drug Conjugates and initiates review of strategic options for its tunable ADC & drug conjugates platforms

Weekly Digest – February 2025 Weekly Digest – February 2025 24 Feb 2025: OS Therapies forms subsidiary OS Drug Conjugates and initiates review of strategic options for its tunable ADC & drug conjugates platforms OS Therapies has launched a subsidiary, […]

by Sandhya Ramalingam

Continue Reading
Approval  ·  Weekly Digest 15 Feb to 21 Feb 2025
1st Trop-2 ADC Trodelvy expands indication to metastatic HR+/HER2- breast cancer

Weekly Digest – February 2025 Weekly Digest – February 2025 14 Feb 2025: 1st Trop-2 ADC Trodelvy expands indication to metastatic HR+/HER2- breast cancer Trodelvy (Sacituzumab govitecan) received expanded approval in Korea to treat metastatic HR+/HER2- breast cancer resistant to […]

by Sandhya Ramalingam

Continue Reading
Clinical  ·  Weekly Digest 15 Feb to 21 Feb 2025
Corbus posts first US data on challenger to Pfizer’s ADC Padcev

Weekly Digest – February 2025 Weekly Digest – February 2025 19 Feb 2025: Corbus posts first US data on challenger to Pfizer’s ADC Padcev Corbus Pharmaceuticals’ western trial of its ADC showed a 27% response rate, aligning with prior Chinese […]

by Sandhya Ramalingam

Continue Reading
« First‹ Previous515253545556575859Next ›Last »
Page 55 of 63


Contact:

  info@ciscientists.com

 +1-908-212-7484

Optimal Dose

For a subscription, please provide your email id